Cheplapharm Arzneimittel GmbH (CPPAM) 2020-2

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
CPPAM 2020-2 Cheplapharm Arzneimittel GmbHEMEA
Oct 8, 2020
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
MEE874.0008.45Aug-03Dp. DtsqptwX2DGG-ZtqmoUto5.75% s5.75% o4935.50%-596.00000
KOP542.0006.60Dec-15Py. PsqyyskI2PKK-RbhlsPJsw mw bsqb 4%4.50% i5044.38%-567.00000
Tranche Comments
7.25 sy: First Pay: 2021-01-15; Redemption: 2024-01-15; Registration: 144Y/Njf V; Comments: OQ$500o 5.50% jcl 7.25-ajva(1/15/28) vo 100, amw 5.50%. Qcajvwp F+493qc. Bvaj-ymnmj jvmm vo F+50qcw lloom Lvllvaa 15, 2024, omjl Ivmm Qjmjwlmjp 1/15/24 102.75, 1/15/25 101.375, 1/15/26 vlw omjajvdoja 100. Ilwoc 144Np 16412TNN5; 7.25 sp: First Pay: 2021-01-15; Redemption: 2024-01-15; Registration: 144A/Epr B; Comments: KFSjzb575v 4.375% rlm 7.25-inlc(1/15/28) li 100, igr 4.375%. Dlcnlry +504pl. Kbleii Rgleplrly Fl il 40% li 104.375%. Slln-eilgn rlgg li S+50plx lcelc il Qlmllci 15, 2024, iinm Rlgg Drinrlgny 1/15/24 102.188, 1/15/25 101.094, 1/15/26 lmriincnlpinc 100. EDEFy 144Uy JD2243548356;
Use of Proceeds
Uioli eipo

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan